Antiamoebal treatments received by acanthamoeba keratitis patients in the survey
| Treatments received (in combination or separately) | No (%) |
|---|---|
| Propamidine + polyhexamethyl biguanide (PHMB) | 108 (50) |
| Propamidine + neomycin + PHMB | 31 (14) |
| Propamidine + neomycin | 16 (7) |
| Propamidine + chlorhexidine | 15 (7) |
| Propamidine + neomycin + chlorhexidine | 12 (6) |
| Propamidine + PHMB + chlorhexidine | 8 (4) |
| Propamidine + neomycin + PHMB + chlorhexidine | 7 (3) |
| Propamidine + PHMB + topical antifungal | 6 (3) |
| Propamidine alone | 5 (2) |
| Propamidine + neomycin + PHMB + topical antifungal | 3 (1) |
| Propamidine + chlorhexidine + topical antifungal | 1 (<1) |
| Propamidine + neomycin + chlorhexidine + topical antifungal | 1 (<1) |
| Propamidine + PHMB + oral antifungal | 1 (<1) |
| Propamidine + neomycin + PHMB + oral antifungal | 1 (<1) |
| Propamidine + neomycin + PHMB + topical and oral antifungal | 1 (<1) |
| Propamidine + neomycin + PHMB + oral antifungal + topical interferon | 1 (<1) |
| Propamidine + neomycin + PHMB + oral metronidazole | 1 (<1) |
| Total | 218 (100) |
↵Data were insufficient for 25 patients.